| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | 10% Owner | Director, 10% Owner +2 more
6 companies
English Aron R. is a Director, 10% Owner at Anebulo Pharmaceuticals, Inc. with holdings across 6 companies. Recent SEC Form 4 filings include 26 buys and 0 sells.
Estimated insider holdings value: $67.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2025 | CULP Culp Inc | 10% Owner | Buy | 124,738 | $5.39 | $672,302.30 | +3.5% | -30.0% | -47.0% | |
| Mar 17, 2025 | CULP Culp Inc | 10% Owner | Buy | 23,019 | $5.09 | $117,249.28 | +0.4% | -23.1% | -41.4% | |
| Mar 12, 2025 | CULP Culp Inc | 10% Owner | Buy | 86,589 | $4.94 | $428,164.00 | +1.7% | -25.4% | -45.9% | |
| Dec 23, 2024 | ANEB Anebulo Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 10,101,010 | $0.99 | $9,999,999.90 | +188.2% | +26.4% | -4.8% | |
| Dec 20, 2024 | CULP Culp Inc | 10% Owner | Buy | 13,444 | $5.24 | $70,486.52 | +0.3% | -2.6% | -36.7% | |
| Dec 11, 2024 | CULP Culp Inc | 10% Owner | Buy | 16,881 | $5.06 | $85,450.79 | +0.4% | -6.3% | -30.3% | |
| Sep 19, 2024 | CULP Culp Inc | 10% Owner | Buy | 240,047 | $6.09 | $1,461,583.39 | +5.6% | -17.2% | -32.8% | |
| Sep 11, 2024 | CULP Culp Inc | 10% Owner | Buy | 14,629 | $5.39 | $78,805.34 | +0.4% | -9.1% | -19.8% | |
| Jul 19, 2024 | CULP Culp Inc | 10% Owner | Buy | 11,041 | $5.20 | $57,449.55 | +0.3% | +12.5% | -16.2% | |
| Jul 16, 2024 | CULP Culp Inc | 10% Owner | Buy | 22,978 | $5.12 | $117,729.81 | +0.9% | +12.4% | -13.3% |